pWZL Sox2 Citations (1)
Originally described in: SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A, Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Jr UR, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M Nat Genet. 2009 Nov . 41(11):1238-42. PubMed Journal
Articles Citing pWZL Sox2
| Articles |
|---|
| SIX1 represses senescence and promotes SOX2-mediated cellular plasticity during tumorigenesis. De Lope C, Martin-Alonso S, Auzmendi-Iriarte J, Escudero C, Mulet I, Larrasa-Alonso J, Lopez-Antona I, Matheu A, Palmero I. Sci Rep. 2019 Feb 5;9(1):1412. doi: 10.1038/s41598-018-38176-0. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.